10:53 AM EST - Fennec Pharmaceuticals Inc. : Reported financial results for the fiscal year ended December 31, 2018. Cash and cash equivalents were $22.8 million as of December 31, 2018. Net losses for the year were $9.9 million ($0.52 per share), compared to $7.0 million ($0.47 per share), respectively, for the same period in 2017. Fennec Pharmaceuticals Inc.
shares T.FRX are trading down $0.72 at $8.33.
